BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 29120525)

  • 1. Heparanase level and procoagulant activity are reduced in severe sepsis.
    Matan M; King D; Peled E; Ackerman S; Bar-Lavi Y; Brenner B; Nadir Y
    Eur J Haematol; 2018 Feb; 100(2):182-188. PubMed ID: 29120525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparanase procoagulant activity is elevated and predicts survival in non-small cell lung cancer patients.
    Nadir Y; Sarig G; Axelman E; Meir A; Wollner M; Shafat I; Hoffman R; Brenner B; Vlodavsky I; Haim N
    Thromb Res; 2014 Sep; 134(3):639-42. PubMed ID: 25065557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An assay to evaluate heparanase procoagulant activity.
    Nadir Y; Kenig Y; Drugan A; Shafat I; Brenner B
    Thromb Res; 2011 Oct; 128(4):e3-8. PubMed ID: 21481923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparanase procoagulant activity, factor Xa, and plasminogen activator inhibitor 1 are increased in shift work female nurses.
    Nadir Y; Saharov G; Hoffman R; Keren-Politansky A; Tzoran I; Brenner B; Shochat T
    Ann Hematol; 2015 Jul; 94(7):1213-9. PubMed ID: 25743687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparanase procoagulant activity is elevated in women using oral contraceptives.
    Matan M; Axelman E; Brenner B; Nadir Y
    Hum Reprod; 2013 Sep; 28(9):2372-80. PubMed ID: 23800622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased heparanase level and procoagulant activity in orthopedic surgery patients receiving prophylactic dose of enoxaparin.
    Peled E; Rovitsky A; Axelman E; Norman D; Brenner B; Nadir Y
    Thromb Res; 2012 Jul; 130(1):129-34. PubMed ID: 22154361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparanase procoagulant activity in cancer progression.
    Nadir Y; Brenner B
    Thromb Res; 2016 Apr; 140 Suppl 1():S44-8. PubMed ID: 27067977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Coagulation tests in septic surgical patients].
    Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
    Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparanase procoagulant activity as a predictor of wound necrosis following diabetic foot amputation.
    Peled E; Melamed E; Portal TB; Axelman E; Norman D; Brenner B; Nadir Y
    Thromb Res; 2016 Mar; 139():148-53. PubMed ID: 26916313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptides inhibiting heparanase procoagulant activity significantly reduce tumour growth and vascularisation in a mouse model.
    Crispel Y; Axelman E; Tatour M; Kogan I; Nevo N; Brenner B; Nadir Y
    Thromb Haemost; 2016 Sep; 116(4):669-78. PubMed ID: 27535490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel peptides that inhibit heparanase activation of the coagulation system.
    Axelman E; Henig I; Crispel Y; Attias J; Li JP; Brenner B; Vlodavsky I; Nadir Y
    Thromb Haemost; 2014 Sep; 112(3):466-77. PubMed ID: 25030319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparanase procoagulant activity.
    Nadir Y; Brenner B
    Thromb Res; 2012 Apr; 129 Suppl 1():S76-9. PubMed ID: 22682139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the heparanase procoagulant domain in bleeding and wound healing.
    Crispel Y; Ghanem S; Attias J; Kogan I; Brenner B; Nadir Y
    J Thromb Haemost; 2017 Jul; 15(7):1463-1472. PubMed ID: 28439967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of activated partial thromboplastin time waveform analysis for identification of sepsis and overt disseminated intravascular coagulation in patients admitted to a surgical intensive care unit.
    Dempfle CE; Lorenz S; Smolinski M; Wurst M; West S; Houdijk WP; Quintel M; Borggrefe M
    Crit Care Med; 2004 Feb; 32(2):520-4. PubMed ID: 14758173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progestin type affects the increase of heparanase level and procoagulant activity mediated by the estrogen receptor.
    Treger S; Ackerman S; Kaplan V; Ghanem S; Nadir Y
    Hum Reprod; 2021 Jan; 36(1):61-69. PubMed ID: 33306105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparanase Level and Procoagulant Activity Are Increased in Thalassemia and Attenuated by Janus Kinase 2 Inhibition.
    Ghoti H; Ackerman S; Rivella S; Casu C; Nadir Y
    Am J Pathol; 2020 Oct; 190(10):2146-2154. PubMed ID: 32745462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparanase in the Coagulation System.
    Nadir Y
    Adv Exp Med Biol; 2020; 1221():771-784. PubMed ID: 32274737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombin levels, morbidity, and mortality in a surgical intensive care unit.
    Sakr Y; Reinhart K; Hagel S; Kientopf M; Brunkhorst F
    Anesth Analg; 2007 Sep; 105(3):715-23. PubMed ID: 17717229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous thrombin potential as marker of procoagulant response that can be useful in early stage of sepsis.
    Mihajlovic D; Brkic S; Lendak D; Novakov Mikic A; Draskovic B; Mitic G
    Blood Coagul Fibrinolysis; 2017 Sep; 28(6):460-467. PubMed ID: 28166112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparanase enhances the generation of activated factor X in the presence of tissue factor and activated factor VII.
    Nadir Y; Brenner B; Fux L; Shafat I; Attias J; Vlodavsky I
    Haematologica; 2010 Nov; 95(11):1927-34. PubMed ID: 20634491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.